1. Home
  2. SLNG vs IKNA Comparison

SLNG vs IKNA Comparison

Compare SLNG & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNG
  • IKNA
  • Stock Information
  • Founded
  • SLNG 2013
  • IKNA 2016
  • Country
  • SLNG United States
  • IKNA United States
  • Employees
  • SLNG N/A
  • IKNA N/A
  • Industry
  • SLNG Oil/Gas Transmission
  • IKNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLNG Utilities
  • IKNA Health Care
  • Exchange
  • SLNG Nasdaq
  • IKNA Nasdaq
  • Market Cap
  • SLNG 85.4M
  • IKNA 81.6M
  • IPO Year
  • SLNG N/A
  • IKNA 2021
  • Fundamental
  • Price
  • SLNG $7.79
  • IKNA $1.46
  • Analyst Decision
  • SLNG Strong Buy
  • IKNA Buy
  • Analyst Count
  • SLNG 1
  • IKNA 2
  • Target Price
  • SLNG $12.00
  • IKNA $3.00
  • AVG Volume (30 Days)
  • SLNG 28.9K
  • IKNA 173.8K
  • Earning Date
  • SLNG 03-05-2025
  • IKNA 03-11-2025
  • Dividend Yield
  • SLNG N/A
  • IKNA N/A
  • EPS Growth
  • SLNG N/A
  • IKNA N/A
  • EPS
  • SLNG 0.21
  • IKNA N/A
  • Revenue
  • SLNG $74,044,000.00
  • IKNA $659,000.00
  • Revenue This Year
  • SLNG N/A
  • IKNA N/A
  • Revenue Next Year
  • SLNG N/A
  • IKNA N/A
  • P/E Ratio
  • SLNG $36.44
  • IKNA N/A
  • Revenue Growth
  • SLNG N/A
  • IKNA N/A
  • 52 Week Low
  • SLNG $3.77
  • IKNA $1.22
  • 52 Week High
  • SLNG $8.28
  • IKNA $1.94
  • Technical
  • Relative Strength Index (RSI)
  • SLNG 64.14
  • IKNA 43.06
  • Support Level
  • SLNG $5.95
  • IKNA $1.40
  • Resistance Level
  • SLNG $8.28
  • IKNA $1.48
  • Average True Range (ATR)
  • SLNG 0.73
  • IKNA 0.06
  • MACD
  • SLNG 0.03
  • IKNA 0.00
  • Stochastic Oscillator
  • SLNG 81.44
  • IKNA 50.00

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Share on Social Networks: